OTC industry efforts contribute to decline in pediatric emergency room visits
WASHINGTON – There has been a declining number of emergency department visits due to children ingesting medications without supervision since 2010, according to an article published in Pediatrics the official journal of the American Academy of Pediatrics, on Tuesday.
After rising steadily from 2004 through 2010, the number of ED visits for these exposures peaked in 2010. According to the article, after 2010 this trend reversed, and visits decreased by an average of 6.7% annually.
“Keeping young children safe by preventing them from accidentally ingesting medicines while unsupervised is of the utmost importance to the makers of over-the-counter medicines,” stated Scott Melville, president and CEO for the Consumer Healthcare Products Association. “We are encouraged that this decrease demonstrates that industry’s voluntary labeling and packaging efforts as well as our educational partnerships are keeping kids safe," he said.
CHPA is involved in a number of long-term efforts targeted at preventing accidental, unsupervised ingestion of medicines by young children. "The most impactful solution is storing all medicines up and away and out of children's reach and sight every time they are used," Melville said. "Through Up and Away and Out of Sight, a campaign led by CHPA’s Educational Foundation and the U.S. Centers for Disease Control and Prevention’s PROTECT Initiative, CHPA works to remind parents and caregivers to take this step."
CHPA member manufacturers also voluntarily added flow restrictors to infants’ and children’s liquid acetaminophen products in 2011. Flow restrictors are one tool for parents in keeping their children safe because they reduce the amount of medicine that can be ingested if the package is not properly closed or if the child-resistant packaging is defeated.
RockTape targets new patient populations with kinesiology tape
CAMPBELL, Calif. – RockTape on Tuesday introduced RockTapeRx, a new gentle kinesiology tape with the same stretch characteristics as RockTape's sport-focused kinesiology tapes.
"We've always been a performance-oriented brand," said Greg van den Dries, CEO of RockTape. "As we grew, it became clear we needed to offer the quality of RockTape to a whole new group of customers with special needs."
RockTapeRx's new gentle adhesive is ideal for special patient populations, including children, the elderly, those with neurological disorders, and women who are pregnant. It's also a great option for those with sensitive skin.
"Our medical practitioners have been demanding this product for quite some time," said Steve Capobianco, director of medical affairs for RockTape.
RockTapeRx is launching exclusively in two-inch bulk rolls with five colors: red, black, beige, pink and blue.
RockTapeRx is available now through RockTape.com and medical distributors nationwide, the company noted.
Mylan pushes forward in its Perrigo takeover bid
HERTFORDSHIRE, England — Mylan will be taking its offer to acquire Perrigo directly to Perrigo shareholders on Sept. 14, the company announced Tuesday. Under the terms of the offer, Perrigo shareholders will receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.
Mylan executive chairman Robert Coury also sent a letter to Perrigo chairman and CEO Joseph Papa reiterating Mylan's commitment to the transaction and respect for Perrigo and its employees, re-affirming the value of the Mylan offer to Perrigo shareholders and outlining to Perrigo shareholders their clear and direct pathway to completion of the transaction.
“We are very excited to commence the final step in this transaction and to complete the compelling combination of Mylan and Perrigo,” Coury stated. “[W]e believe this is a highly attractive offer for Perrigo shareholders in terms of the price, multiple being paid, accretion and continued long-term potential for value creation," he said. "We are confident that Perrigo shareholders see that our offer provides superior immediate value, as well as long-term, sustainable value creation, and will tender in favor of the transaction.”
As previously announced on April 24, 2015, Mylan issued a Rule 2.5 announcement under the Irish Takeover Rules setting forth its legally-binding commitment to commence an offer for the entire issued and to be issued shares of Perrigo. Mylan’s shareholders approved the bid at their annual meeting on Aug. 28.
Perrigo believes the takover offer is undervalued.
“Our views of Mylan's offer to Perrigo shareholders have always been, and will continue to be, based on our board's careful reflection of the value available to Perrigo shareholders, and do not depend on the limited choices that Mylan has allowed its shareholders to consider,” stated Papa, late last month following a Mylan shareholder vote to pursue the acquisition. “Following extensive discussions with our shareholders, we are confident that most of them believe that Mylan's offer substantially undervalues Perrigo and would dilute our growth profile and superior valuation.”
Loading Post Please Wait...